Analystreport

Leap Therapeutics Inc (NASDAQ: LPTX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $6.00 price target on the stock.

Leap Therapeutics, Inc.  (LPTX) 
Last leap therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.leaptx.com